Spots Global Cancer Trial Database for pyrotinib 320mg + vinorelbine
Every month we try and update this database with for pyrotinib 320mg + vinorelbine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer | NCT04605575 | Breast Cancer Pyrotinib Breast Diseases Vinorelbine HER2-positive B... | Pyrotinib 320mg... Pyrotinib 400mg... Pyrotinib plus ... | 18 Years - 70 Years | Sun Yat-sen University | |
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer | NCT04605575 | Breast Cancer Pyrotinib Breast Diseases Vinorelbine HER2-positive B... | Pyrotinib 320mg... Pyrotinib 400mg... Pyrotinib plus ... | 18 Years - 70 Years | Sun Yat-sen University |